Wuhan Wansheng Biotechnology: difference between revisions

Diff·revision 27 → 28·09:04, 22 Nov 2024

Difference between revision 27 and revision 28 of Wuhan Wansheng Biotechnology. 7 lines changed; the page grew by 482 bytes.

Revision 27 — 06:17, 14 Nov 2024 AnalyticalAnnie (talk) expand §Independent testing record 5,929 bytes ±0	Revision 28 — 09:04, 22 Nov 2024 LotTraceLuka (talk) attribute range as a review estimate per talk 6,411 bytes +482
12	\| Industry = Research-compound supply	12	\| Industry = Research-compound supply
13	\| Shop domain = [https://wuhanwanshengbio.com/ Visit WWB]	13	\| Shop domain = [https://wuhanwanshengbio.com/ Visit WWB]
+		14	<!-- Products and documentation -->
+		15	\| Product scope = peptides, SARMs, injectable materials and raw materials
+		16	\| Catalogue size = Not documented
+		17	\| Documentation = Batch certificate of analysis reported with orders
+		18	\| Independent reports = Submitted to this wiki by purchasers; see §Independent testing record
14	}}	19	}}
15	{{hatnote\|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}}	20	{{hatnote\|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}}
⋮		⋮
41	\| SARMs \| Bulk and capsuled \| Certificate, purity \|	46	\| SARMs \| Bulk and capsuled \| Certificate, purity \|
42	\| Injectable and raw materials \| Bulk \| Certificate, limited detail \|	47	\| Injectable and raw materials \| Bulk \| Certificate, limited detail \|
+		48
+		49	The catalogue is broad and the documentation inconsistent across it — an unusual combination, and one that makes generalisation from any single order unsafe.{{r\|reports}}
43		50
44	== References ==	51	== References ==